This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar;141(3):825.

doi: 10.1378/chest.11-2079.

Bronchiectasis: defining specific treatment needs

Rob G Stirling¹

Affiliations

Affiliation

¹ Department of Allergy, Immunology and Respiratory Medicine, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia. Electronic address: r.stirling@alfred.org.au.

PMID: 22396571
DOI: 10.1378/chest.11-2079

Comment

Bronchiectasis: defining specific treatment needs

Rob G Stirling. Chest. 2012 Mar.

. 2012 Mar;141(3):825.

doi: 10.1378/chest.11-2079.

Author

Rob G Stirling¹

Affiliation

¹ Department of Allergy, Immunology and Respiratory Medicine, Monash University, The Alfred Hospital, Melbourne, Victoria, Australia. Electronic address: r.stirling@alfred.org.au.

PMID: 22396571
DOI: 10.1378/chest.11-2079

No abstract available

PubMed Disclaimer

Comment on

Clinical efficacy and safety of budesonide-formoterol in non-cystic fibrosis bronchiectasis.
Martínez-García MÁ, Soler-Cataluña JJ, Catalán-Serra P, Román-Sánchez P, Tordera MP. Martínez-García MÁ, et al. Chest. 2012 Feb;141(2):461-468. doi: 10.1378/chest.11-0180. Epub 2011 Jul 21. Chest. 2012. PMID: 21778259 Clinical Trial.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources